Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 3 2Phase 2 2Phase 1/2 2Phase NA 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Lymphoid 1

Conditions

Nasopharyngeal Carcinoma 26Prostatic Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Nasopharyngeal Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 5Uterine Cervical Neoplasms 4Oropharyngeal Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Radiation Injuries 2Neurotoxicity Syndromes 2Hypopharyngeal Neoplasms 2Glioblastoma 2Carcinoma 2Brain Neoplasms 2Astrocytoma 2Vaginal Neoplasms 1Thoracic Neoplasms 1Stage II Prostate Adenocarcinoma AJCC v7 1Sarcoma 1Precancerous Conditions 1Postoperative Complications 1Papillomavirus Infections 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ototoxicity 1Oligodendroglioma 1

Interventions

Temozolomide 16Radiotherapy 11Lomustine 8Carmustine 6Vincristine 5Procarbazine 5Etoposide 3Corticotropin-Releasing Hormone 3Carboplatin 3vorasidenib 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Isotretinoin 2Everolimus 2Dihematoporphyrin Ether 2Cisplatin 2Chemotherapy, Adjuvant 2etoposide phosphate 1carmustine, poliferprosan 20 drug combination 1Valproic Acid 1Tranexamic Acid 1Trabedersen 1Thioguanine 1Surgical Procedures, Operative 1Semustine 1Radiotherapy, Conformal 1Radiosurgery 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Astrocytoma × Radiotherapy, Intensity-Modulated × Clear all
NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Not yet recruiting
408 enrolled
CNSLymphoid

Astrocytoma, Lymphoma, Follicular

NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡